Mereo BioPharma MREO
NASDAQ MREO
$0.29 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) Net Equity Issued and Repurchased (2023 - 2025)

Updated

Mereo BioPharma (MREO) reported Net Equity Issued and Repurchased of $487,000 for FY2025, down 99.0% from $47 million in FY2024.

Analysis

Mereo BioPharma (MREO) Net Equity Issued and Repurchased (2023 - 2025) Analysis & Trends

  • According to Business Quant data, Net Equity Issued and Repurchased came in at $47 million in FY2024 (+305.0%) and $11.61 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -966.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -9.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 6.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -346.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Mereo BioPharma 46.31 Mn -103.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 39,000.00
Mar 31, 2025 487,000.00
Jun 30, 2024 47.00 Mn
Sep 30, 2023 11.61 Mn
API Access

Mereo BioPharma Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MREO&period=max&api_key=YOUR_API_KEY